Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation

Cell

Volumn 72, Issue 3, 1993, Pages 309-324

  Gu, Wei ^a,b   Schneider, Jay W ^a,b   Condorelli, Gianluigi ^a,b   Kaushal, Sunjay ^a,b   Mahdavi, Vijak ^a,b   Nadal Ginard, Bernardo ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL EXTRACT; HYBRID PROTEIN; MYOGENIN; PROTEIN KINASE; VIRUS T ANTIGEN;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DNA INTERACTION; PROTEIN PHOSPHORYLATION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ANTIGENS, POLYOMAVIRUS TRANSFORMING; BASE SEQUENCE; CELL CYCLE; CELL DIFFERENTIATION; DNA REPLICATION; HUMAN; IN VITRO; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; MUSCLES; MYOD PROTEIN; OLIGODEOXYRIBONUCLEOTIDES; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN P34CDC2; RETINOBLASTOMA PROTEIN; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0027499060     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(93)90110-C     Document Type: Article

References (98)

1. The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F
2. Cyclin A and the retinoblastoma gene product complex with a common transcription factor
3. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins
4. Functional antagonism between c-Jun and MyoD proteins: a direct physical association
5. Structure and expression of the murine retinoblastoma gene and characterization of its encoded protein
6. Cytoplasmic activation of human nuclear genes in stable heterokaryons
7. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene
8. A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts
9. 3H1 cells
10. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle
11. The E2F transcription factor is a cellular target for the RB protein
12. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation
13. Identification of a region of simian virus 40 large T antigen required for cell transformation
14. The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein
15. MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes
16. Requirement for a functional Rb-1 gene in murine development
17. MyoD induces growth arrest independent of differentiation in normal and transformed cells
18. Expression of a single transfected cDNA converts fibroblasts to myoblasts
19. The MyoD DNA-binding domain contains a recognition code for muscle-specific gene activation
20. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
21. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element
22. Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product
23. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
24. Large T-antigens of many polyoma viruses are able to form complexes with the retinoblastoma protein
25. Transcriptional and posttranscriptional control of c-myc during myogenesis: its mRNA remains inducible in differentiated cells and does not suppress the differentiated phenotype
26. SV40 large T-antigen induces re-entry of terminally differentiated myotubes into the cell cycle
27. Infection of muscle cultures from various species with oncogenic DNA viruses (SV40 and polyoma)
28. Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and non-cycling human hematopoietic cells
29. A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells
30. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle
31. The relationship of polyoma virus-induced tumor (T) antigen to activation of DNA synthesis in rat myotubes
32. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F
33. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
34. Expression of the MyoD1 muscle determination gene defines differentiation capacity but not tumorigenicity of human rhabdomyosarcomas
35. Effect of oncogenic virus on muscle differentiation
36. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells
37. HEB, a helix-loop-helix protein related to E2A and ITF2 that can modulate the DNA-binding ability of myogenic regulatory factors
38. The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations
39. Antibodies specific for the human retinoblastoma protein identify a family of related polypeptides
40. The retinoblastoma protein physically associates with the human cdc2 kinase
41. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells
42. Effects of an Rb mutation in the mouse
43. Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product
44. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product
45. In vitro mutagenesis of a putative DNA-binding domain of SV40 large T
46. A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding
47. The dissociability of deoxyribonucleic acid synthesis from the development of multinuclearity of muscle cells in culture
48. Interaction with normal cells suppresses the transformed phenotype of v-myc-transformed quail muscle cells
49. MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer
50. Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1
51. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo
52. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
53. Human retinoblastoma susceptibility gene: cloning, identification and sequence
54. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA-binding activity
55. The retinoblastoma protein is phosphorylated on multiple sites by human cdc2
56. Fos and Jun repress transcriptional activation by myogenin and MyoD: the amino terminus of Jun can mediate repression
57. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase
58. SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family
59. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T
60. Tumor suppressor genes
61. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product
62. C-myc inhibition of MyoD- and myogenin-initiated myogenic differentiation
63. G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment
64. In vivo footprinting of a muscle specific enhancer by ligation mediated PCR
65. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughter-less, MyoD and myc proteins
66. B-cell and myocyte-specific E2-box-binding factors contain E12/E47-like subunits
67. Commitment, fusion, and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis
68. Reversibility of muscle differentiation in the absence of commitment: analysis of a myogenic cell line temperature-sensitive for commitment
69. Universal control mechanism regulating onset of M-phase
70. MyoD family: a paradigm for development?
71. Association of cdk-2 kinase with the transcription factor E2F during S-phase
72. Identification of a growth suppression domain within the retinoblastoma gene product
73. Negative regulation of human c-fos expression by the retinoblastoma gene product
74. Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product
75. The state of the p53 and the retinoblastoma genes in human cervical carcinoma cell lines
76. Regulation, linkage, and sequence of mouse metallothionein I and II genes
77. Deletion of a splice donor site ablates expression of the following exon and produces an unphosphorylated RB protein unable to bind SV40 T-antigen
78. C-terminal truncation of the retinoblastoma gene product leads to functional inactivation
79. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner
80. Cell proliferation inhibited by MyoD1 independently of myogenic differentiation
81. Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts
82. DNA synthesis and myogenesis
83. MyoD and the regulation of myogenesis by helix-loop-helix proteins
84. MyoD: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblast to myoblasts
85. The expression of sarcomeric muscle-specific contractile protein genes in BC3H1 cells: BC3H1 cells resemble skeletal myoblasts that are defective for commitment to terminal differentiation
86. Temperature sensitive mutant of simian virus 40 infection of permissive cells
87. A transcriptional tryst
88. Adenovirus E1A products suppress myogenic differentiation and inhibit transcription from muscle-specific promoters
89. Tumor suppressor genes
90. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD
91. The myoD gene family: nodal point during specification of the muscle cell lineage
92. Human chromosome 11 contains two different growth suppressor genes for embryonic rhabdomyosarcoma
93. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product
94. Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor
95. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD
96. Multinucleated muscle fibers: induction of DNA synthesis and mitosis by polyoma virus infection
97. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle
98. Differential trans-activation association with the muscle regulatory factors MyoD1, myogenin, and MRF4